"Located in downtown Toledo along Summit and Madison streets, the ProMedica Headquarters campus hosts the systems corporate offices in four main buildings, including the Steam Plant, the Summit Center, the Junction and the Plaza."

During the past decade, ProMedica Health System conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProMedica Health System" #1 sponsor was "Abbott Nutrition" with 1 trials, followed by "Impulse Dynamics" with 1 trials sponsored, "Mereo BioPharma" with 1 trials sponsored, "Merrimack Pharmaceuticals" with 1 trials sponsored and "Telik" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProMedica Health System" #1 collaborator was "ARMS Pharmaceutical LLC" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "Pediatric Pharmacology Research Center" with 1 trials as a collaborator, "ProMedica Health System" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "ProMedica Health System" are "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Foot Ulcer, Diabetic" (1 trials), "Heart Failure" (1 trials) and "Non-Small-Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "ProMedica Health System" in a lesser frequency.

Most popular intervention types in "ProMedica Health System" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARMS-I" (1 trials), "BGS649" (1 trials), "Doxorubicin HCl Liposome Injection" (1 trials), "Drink mix calorically similar to experimental product" (1 trials) and "MM-121" (1 trials). Other intervention names were less common.

The vast majority of trials in "ProMedica Health System" are 4 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "ProMedica Health System". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ProMedica Health System, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ProMedica Health System, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".